Beyond Labels: AI’s Ascent in Biomedical Discovery

by

Author: Denis Avetisyan

As manually annotating biological and medical data becomes increasingly challenging, artificial intelligence is stepping in to unlock insights through methods that learn without constant human guidance.

This review explores the emerging role of unsupervised, self-supervised, and generative models in overcoming annotation bottlenecks across fields like medical imaging and bioinformatics.

The reliance on painstakingly curated, manually annotated datasets has long constrained the progress of artificial intelligence in biomedicine. This challenge is addressed in ‘Transcending the Annotation Bottleneck: AI-Powered Discovery in Biology and Medicine’, which details a paradigm shift towards unsupervised and self-supervised learning (SSL) methods capable of extracting meaningful insights directly from raw biomedical data. These approaches-leveraging the intrinsic structure of images, scans, and genomic sequences-are demonstrating performance comparable to, and often exceeding, traditionally supervised techniques while bypassing the limitations of human annotation. Will these “learning without labels” frameworks unlock a new era of scalable and unbiased discovery in biology and medicine?

The Algorithm Unveiled: Addressing Data Scarcity

Biomedical research frequently encounters a substantial obstacle in the form of labeled data scarcity. Traditional supervised learning algorithms, while powerful, demand vast quantities of meticulously annotated examples – a process that is often time-consuming, expensive, and requires specialized expertise. Constructing these datasets for complex biological phenomena presents a unique challenge, as acquiring accurate labels can necessitate invasive procedures, lengthy observation periods, or reliance on subjective interpretations. This bottleneck significantly hinders progress in areas like disease diagnosis, drug discovery, and personalized medicine, where the sheer volume and diversity of biological data often outpace the capacity for manual annotation. Consequently, the field is actively exploring alternative machine learning paradigms that can circumvent this dependency on labeled data, unlocking the potential of the wealth of currently untapped biomedical information.

Biological systems are characterized by an intricate web of interactions and dependencies, generating data with inherent noise and complexity that often defies straightforward interpretation. Consequently, relying solely on labeled datasets-where humans predefine categories or outcomes-can severely limit a model’s ability to capture the full richness of these systems. Instead, methods that can learn directly from the raw, unlabeled data – such as genomic sequences, proteomic profiles, or medical images – offer a powerful alternative. These approaches aim to autonomously discover the underlying structure and patterns within the data, revealing previously unknown relationships and potentially identifying critical biomarkers or therapeutic targets. This ability to extract knowledge without explicit human guidance is not merely a technological advancement; it represents a paradigm shift in biomedical research, allowing for exploration beyond the confines of pre-defined hypotheses and opening doors to truly novel discoveries.

The escalating complexity of modern biomedical data is driving a need for algorithms capable of independent feature engineering. Rather than relying on human experts to predefine relevant characteristics within datasets, researchers are increasingly focused on techniques that can autonomously discover and represent underlying patterns. These methods, often rooted in neural networks and dimensionality reduction, aim to learn compressed, informative representations directly from raw, unlabeled data. This progression towards self-representation not only bypasses the laborious and costly process of manual annotation but also holds the potential to reveal previously unknown biological insights, as algorithms can identify subtle correlations and structures that might elude human observation. The ability to learn without explicit guidance marks a significant step towards creating truly intelligent systems capable of navigating the intricacies of biological systems.

A paradigm shift is occurring in machine learning, as recent innovations in unsupervised learning are demonstrating performance levels previously thought exclusive to supervised approaches. Historically, training algorithms demanded meticulously labeled datasets – a costly and time-consuming endeavor, particularly within the complexities of biomedical research. However, novel techniques, including self-supervised learning and generative models, now enable algorithms to discern patterns and extract meaningful features directly from raw, unlabeled data. This progression isn’t merely incremental; studies reveal that, in specific applications, these unsupervised methods are achieving comparable, and sometimes superior, results to their supervised counterparts. This challenges the long-held assumption that abundant labeled data is a prerequisite for robust and accurate machine learning, opening doors to analyzing the vast quantities of readily available, yet previously untapped, biological information.

Self-Supervision in Practice: Evidence of Algorithmic Insight

DINO and SimCLR are self-supervised learning methods utilizing contrastive learning to generate visual representations from unlabeled images. These techniques operate by training a model to recognize different augmented views of the same image as similar, while distinguishing them from other images in the dataset. This process yields robust feature embeddings, allowing for effective downstream tasks such as semantic segmentation without the need for manually annotated datasets. By learning representations directly from the data itself, these methods reduce the reliance on expensive and time-consuming labeling efforts, and have demonstrated performance comparable to, and in some cases exceeding, supervised approaches on complex image analysis tasks.

scVI, a variational autoencoder-based model, applies self-supervised learning principles to single-cell RNA sequencing (scRNA-seq) data. This approach addresses the challenges of high dimensionality and noise inherent in scRNA-seq by learning a lower-dimensional, latent representation of gene expression. Specifically, scVI models the gene expression matrix as a function of the latent space, incorporating a bias term to account for technical variations between cells. By learning this latent space without requiring labeled data, scVI can effectively uncover hidden structure in gene expression, enabling tasks such as cell type identification, trajectory inference, and the detection of novel cell states. The model uses a negative binomial likelihood to account for the discrete nature of gene expression counts, and is trained using an expectation-maximization algorithm.

DNABERT adapts the Bidirectional Encoder Representations from Transformers (BERT) architecture, originally designed for natural language processing, to the analysis of genomic sequences. This application treats DNA sequences as a language, where nucleotides (A, T, C, G) function analogously to words. By pre-training on large genomic datasets without labeled examples, DNABERT learns contextualized embeddings of DNA sequences. These embeddings enable the identification of regulatory elements – DNA segments that control gene expression – and functional motifs, which are recurring patterns associated with specific biological functions. The model’s ability to understand sequence context improves the accuracy of predicting these elements compared to traditional methods relying on explicit feature engineering.

Cross-modal autoencoders and ContIG represent a computational approach to data analysis that combines information from different modalities, specifically imaging and genetics. These methods utilize autoencoders to learn compressed representations of both imaging data (e.g., microscopy images) and genetic data (e.g., gene expression profiles) within a shared latent space. By integrating these disparate data types, the models can identify correlations and dependencies that would be difficult to discern from either modality alone. ContIG, in particular, focuses on integrating imaging and genetic data to enhance the understanding of cellular phenotypes and their underlying molecular mechanisms, providing a more comprehensive biological interpretation than analyzing each modality in isolation.

Recent evaluations of voxel-wise segmentation demonstrate the competitive performance of unsupervised learning methodologies. Specifically, unsupervised models have achieved an Average Precision (AP) score of 0.830. This result is notable as it rivals, and in some cases exceeds, the performance of traditional supervised learning approaches, which currently yield an AP of 0.751 on the same datasets. This indicates a significant advancement in the ability of algorithms to accurately delineate structures in 3D data without relying on manually annotated training sets.

Refining the Algorithmic Approach: Advanced Techniques in Action

Vision Transformers (ViT) demonstrate efficacy in image analysis due to their attention mechanism, which allows the model to weigh the importance of different image regions when making predictions. Unlike convolutional neural networks that process images locally, ViT divides an image into patches and treats them as tokens, similar to words in natural language processing. This approach facilitates the capture of long-range dependencies and complex spatial relationships within histological slides, enabling the prediction of RNA expression levels based on tissue morphology. The RNAPath and DINO models utilize this capability, effectively linking visual features observed in histology to underlying gene expression patterns and improving the accuracy of computational pathology workflows.

RNAPath is a self-supervised Vision Transformer (ViT) model trained on a large dataset of 1.7 million histological image tiles sourced from the Genotype-Tissue Expression (GTEx) project. This training approach allows the model to learn representations of tissue morphology directly from image data without requiring labeled examples. The substantial size of the training dataset and the ViT architecture enable RNAPath to capture complex patterns within histological images, facilitating the prediction of RNA expression levels based solely on visual features of the tissue architecture. The self-supervised nature of the training allows the model to generalize to new tissue types and conditions beyond those present in any labeled training sets.

Advanced image registration techniques, including VoxelMorph and MICDIR, address the challenge of geometrically aligning anatomical images acquired from different modalities or at varying time points. VoxelMorph employs a deformable registration approach using a voxel-wise displacement field learned through neural networks, enabling accurate alignment even with significant anatomical variations. MICDIR (Multi-resolution Implicit Convolutional Deformation with Regularization) utilizes an implicit representation of the deformation field and incorporates regularization terms to ensure smooth and realistic transformations. These techniques are crucial for improving the accuracy of downstream analyses, such as atlas-based segmentation, quantitative morphometry, and longitudinal studies, by minimizing errors introduced by misalignments and enabling precise comparisons between images.

StRegA and MAD-AD utilize Variational Autoencoders (VAEs) to perform anomaly detection within neuroimaging data. VAEs are generative models that learn a compressed, latent representation of normal brain structure, allowing for reconstruction of input images. Anomalies are identified by quantifying the reconstruction error; significant deviations between the input image and its reconstructed counterpart indicate structural abnormalities. This approach is particularly effective at detecting subtle anomalies that may be missed by visual inspection, as it is sensitive to deviations from the learned distribution of normal brain anatomy. Both StRegA and MAD-AD employ variations of this principle, differing in their specific VAE architectures and training methodologies, but sharing the core principle of leveraging reconstruction error for anomaly identification.

A 3D diffusion autoencoder was employed to generate a reduced-dimensionality representation of cardiac function and anatomy. This autoencoder learned a 182-dimensional latent space capable of encapsulating complex patterns of cardiac wall motion and structural characteristics derived from 3D imaging data. The diffusion process allows for the generation of new, realistic cardiac phenotypes within this latent space, and facilitates the analysis of relationships between latent features and established cardiac pathologies. This dimensionality reduction enables efficient computation and analysis of high-dimensional cardiac imaging data while preserving key information about cardiac function and structure.

Analysis of the 182-dimensional latent space generated by the 3D diffusion autoencoder identified 89 genomic loci exhibiting statistically significant associations with both the derived latent phenotypes and established cardiac diseases. These loci were determined through genome-wide association studies performed on the latent representations, effectively linking structural and functional cardiac phenotypes – as captured by the autoencoder – to known genetic predispositions for conditions like cardiomyopathy, heart failure, and atrial fibrillation. This correlation suggests the latent space accurately represents biologically relevant cardiac traits and provides a novel avenue for investigating the genetic basis of cardiac disease.

BEHRT (Bidirectional Encoder Representations from Transformers) facilitates computational phenotyping by applying transformer architectures to unstructured patient medical histories. This approach moves beyond traditional methods reliant on structured data, such as ICD codes, by directly processing clinical notes, radiology reports, and other textual sources. The transformer model is pre-trained on large corpora of clinical text to learn contextual representations of medical concepts and their relationships. This enables BEHRT to extract nuanced and clinically relevant information from patient records, supporting tasks such as disease prediction, patient stratification, and the identification of novel phenotypic associations. The resulting embeddings can be used as features in downstream machine learning models, improving their performance and interpretability.

The Future of Biomedical AI: Toward Predictive and Proactive Healthcare

The trajectory of healthcare is undergoing a fundamental shift, moving beyond simply responding to illness towards anticipating it. Self-supervised learning, a technique allowing artificial intelligence to glean insights from vast amounts of unlabeled data, is at the forefront of this change. Traditionally, diagnosis relies on identifying established symptoms; however, this approach inherently delays intervention. By analyzing subtle patterns within medical imaging, genomic data, and patient histories-without explicit human annotation-these algorithms can identify pre-symptomatic indicators of disease. This proactive capability promises earlier detection, potentially enabling preventative measures and significantly improving treatment outcomes before conditions become critical, ultimately redefining healthcare from reactive treatment to predictive wellbeing.

The convergence of diverse data streams – medical imaging, genomic sequencing, and detailed clinical records – is enabling the creation of remarkably comprehensive patient profiles. These profiles transcend traditional diagnostic approaches by capturing not just current health status, but also an individual’s predispositions and potential risks. Through the application of sophisticated analytical techniques, these multi-modal datasets reveal subtle patterns and biomarkers indicative of future disease development. This allows for the identification of individuals at high risk, even before the onset of noticeable symptoms, and facilitates the design of preventative interventions tailored to their unique genetic makeup and lifestyle factors. Ultimately, this holistic approach promises a future where healthcare is not simply reactive, but proactively anticipates and addresses health challenges before they escalate.

The future of medicine increasingly centers on tailoring treatments to the individual, a departure from the historically common “one-size-fits-all” approach. This personalized methodology leverages a patient’s unique genetic makeup, lifestyle, and environmental factors to predict their response to therapies. By moving beyond broad classifications of illness, clinicians can select interventions designed to maximize therapeutic benefit while simultaneously minimizing adverse effects. This precision extends beyond drug selection to encompass preventative strategies, diagnostic timing, and even dosage adjustments, promising a healthcare system that is not only more effective but also more efficient and patient-centric. Ultimately, this shift aims to optimize outcomes and improve the overall quality of life by treating the individual, not just the disease.

The trajectory of biomedical artificial intelligence hinges on sustained advancements in self-supervised learning techniques, increasingly sophisticated data integration strategies, and ever-growing computational resources. Future innovations promise a shift beyond merely identifying existing conditions; these technologies are poised to forecast individual health trajectories with unprecedented accuracy. By harmonizing diverse datasets – from high-resolution medical imaging and genomic sequencing to longitudinal clinical records and even lifestyle factors – algorithms can discern subtle patterns indicative of nascent disease. This confluence of power will not only refine predictive models but also enable the development of truly personalized interventions, tailored to preemptively address individual vulnerabilities and optimize preventative care, ultimately reshaping the landscape of human health from reactive treatment to proactive well-being.

The pursuit of robust algorithms within biomedical data analysis, as detailed in the study, echoes a fundamental mathematical principle. The article demonstrates a shift towards self-supervised learning, effectively allowing models to discern patterns without reliance on explicitly labeled data-a process akin to defining invariants as N approaches infinity. Fei-Fei Li aptly stated, “AI is not about replacing humans; it’s about augmenting and amplifying human capabilities.” This aligns perfectly with the paper’s central argument: that unsupervised and self-supervised learning methods can transcend the annotation bottleneck, not by eliminating human expertise, but by enabling it to focus on higher-level interpretation and discovery within the vast landscape of biological and medical data. The models, like elegantly derived equations, aim for a universally applicable truth, minimizing dependence on specific, potentially biased, datasets.

What’s Next?

The demonstrated efficacy of unsupervised and self-supervised learning-while gratifying-should not engender complacency. The field now faces a more subtle, yet critical, challenge: formalizing the very notion of ‘understanding’ within these models. A system can generate plausible biological sequences or identify anomalies in medical images, but does it know what it is doing? Without a precise, mathematically-grounded definition of biological relevance-a definition currently absent from most training objectives-these successes remain, at best, sophisticated pattern matching.

Future work must prioritize the development of provable invariants. Generative models, for example, should not merely produce visually appealing data; they must demonstrably adhere to established biochemical principles. Anomaly detection algorithms require more than statistical outliers; they demand explanations rooted in known biological mechanisms. The pursuit of ‘biological plausibility’ as a quantifiable constraint-a formal specification-is paramount.

Ultimately, the true test lies not in surpassing human annotation, but in exceeding human comprehension. The goal is not simply to automate existing analyses, but to reveal previously inaccessible truths. This requires a shift in emphasis: from empirical performance to mathematical certainty. The age of ‘good enough’ algorithms must give way to an era of provably correct models.

Original article: https://arxiv.org/pdf/2602.20100.pdf

Contact the author: https://www.linkedin.com/in/avetisyan/

See also:

2026-02-24 17:32